WINDLAS1,135.00

Windlas Biotech Limited

· Pharma & Health
₹ CrorePeersHESTERBIOINDOCOSAIPARENTSYNCOMFPANACEABIONGLFINEHIKALJAGSNPHARMMcap ₹2,396 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation13.428.030.7
+ Finance Costs1.14.44.8
+ Interest Income-2.0-1.5-1.2
+ Unrealised FX (Gain) / Loss-0.00.0-0.6
+ Other Non-cash Items4.82.717.7
+ Other Reconciling Items-10.8-15.1-14.8
Changes in Working Capital
+ Inventories12.5-19.219.6
+ Trade Receivables — Current-19.8-30.8-61.0
+ Other Financial Assets — Current0.2-0.50.4
+ Other Financial Assets — Non-current-0.5-0.1-1.2
+ Other Current Assets2.3-7.1-24.2
+ Other Non-current Assets-0.2-0.00.1
+ Trade Payables — Current43.835.760.7
+ Other Financial Liabilities — Current4.84.18.9
+ Other Financial Liabilities — Non-current-0.1-0.10.0
+ Other Current Liabilities0.58.1-7.7
+ Provisions — Current0.30.10.4
+ Provisions — Non-current0.20.60.4
Cash from Operating Activities
Profit Before Tax (per I/S)77.179.887.0
+ Total Adjustments (incl. Working Capital)50.59.333.1
Cash from Operations (pre-tax)127.689.1120.1
+ Income Taxes Paid18.620.915.2
Cash from Operating Activities109.068.2104.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)37.752.267.7
+ Disp of Fixed Assets0.00.20.0
+ Acq of Investment Property56.134.930.2
+ Acq of Other Long-term Assets0.1-11.2-4.8
+ Interest Received — Investing1.71.61.3
Cash from Investing Activities-92.1-74.1-91.8
Cash from Financing Activities
+ Proceeds from Issue of Shares-4.00.00.0
+ Proceeds from Exercise of Stock Options0.04.44.0
+ Proceeds from Borrowings0.027.02.8
+ Repayment of Borrowings0.30.00.0
+ Payment of Lease Liabilities1.514.52.9
+ Interest Paid1.14.44.8
+ Dividends Paid8.311.512.2
Cash from Financing Activities-15.31.0-13.0
Net Changes in Cash (pre-FX)1.6-4.90.1
Net Changes in Cash1.6-4.90.1
Closing Cash5.3
Reference Items
EBITDA78.294.1104.7
EBITDA Margin %12.3912.3811.59
Free Cash Flow (CFO − Capex)71.316.037.3
Free Cash Flow to Equity38.635.2
Free Cash Flow per Basic Share33.777.5817.66
Cash Flow to Net Income1.871.121.58
Cash Paid for Taxes18.620.915.2
Cash Paid for Interest1.14.44.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.